Cleared Traditional

K881342 - IMPLANTOFIX II IMPLANTABLE DRUG DELIVERY SYSTEM

K881342 is an FDA 510(k) clearance for IMPLANTOFIX II IMPLANTABLE DRUG DELIVER..., manufactured by Burron Medical, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 132-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1988
Decision
132d
Days
Class 2
Risk

K881342 is an FDA 510(k) clearance for the IMPLANTOFIX II IMPLANTABLE DRUG DELIVERY SYSTEM. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Burron Medical, Inc. (Bethlehem, US). The FDA issued a Cleared decision on August 9, 1988 after a review of 132 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K881342

510(k) Number K881342 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1988
Decision Date August 09, 1988
Days to Decision 132 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d slower than avg
Panel avg: 129d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 287
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K881342.
A-PORT IMPLANT VASCULAR ACCESS SYSTEM .6MM/2.29MM
K893460 · Therex Corp. · Jun 1989
MODELS 6526,6527,6528 PERCU. TRANS. ANGIO. CATH.
K891611 · Medtronic Versaflex, Inc. · Jun 1989
SINGLE LUMEN S.E.A.-PORT VASCULAR ACCESS SYSTEM
K890518 · Harbor Medical Devices, Inc. · Apr 1989
A PORT IMPLANT VASCULAR ACCESS SYSTEM - DETACHED
K882230 · Therex Corp. · Jul 1988
S.E.A.-PORT(TM) VASCULAR ACCESS SYSTEM
K882190 · Harbor Medical Devices, Inc. · Jun 1988
LIFEPORT II, MODEL LPS-1100
K881075 · Strato Medical Corp. · Jun 1988